US 11123399
Modulators of complement activity
granted A61KA61K38/10A61K38/12
Quick answer
US patent 11123399 (Modulators of complement activity) held by RA PHARMACEUTICALS, INC. expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RA PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/10, A61K38/12, A61K39/3955, A61K47/02